The industry as a whole has an opportunity to build on the initial self-regulation model that has been employed by several pioneering gene synthesis companies.
The claims from He Jiankui that he has used gene editing to produce twin girls demand action. A new registry of research is a good start.
Scientists say there's no certain way to stop someone intent on monkeying with DNA, no matter what laws or standards are in place.
The genome editing of germ cells or early embryos is still in the stage of basic research, and its safety and validity need to be fully evaluated.
Some scientists worry the startling claim will lead to knee-jerk regulations and damage the public’s trust in gene editing.
A Chinese scientist triggered alarm and confusion across the scientific community Monday with the claim that he had edited the DNA of human embryos to create twin girls.
China is ramping up its regulations on the sharing and export of human genetic resources. Experts say breaching of regulations has been common in the past two decades, and a crackdown is necessary.
There are only four companies in the world that have successfully commercialized Botox, but Korea has three: Medytox, Daewoong Pharmaceuticals and Hugel.
Fewer than one-in-10 countries have met global standards for securing high-consequence pathogens, increasing risks of an accidental disease outbreak or bioterrorism, a campaign group has warned. Just 19 countries completing a United Nations safety check have built or shown strong biosecurity safeguards.
The Committee on Foreign Investment in the United States (CFIUS) recently broadened its coverage of biotechnology transactions via new regulations that became effective on November 10, 2018.